While methylation has been well documented in GC-DLBCL [34] there are limited reports on the role of methylation in the ABC-subtype of DLBCL that we have examined as this subtype is responsive to BTK inhibitor therapy. The gene discussed is BTK; the disease is diffuse large B-cell lymphoma.